Nimble Science Ltd.
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Holding
- Established
- 2018-03-13
- Employees
- 11
- Market Cap
- -
- Website
- http://www.nimblesci.com
The Impact of an Oral Nutrition Supplement on the Gut Microbiome in Diabetic Patients
Phase 1
Not yet recruiting
- Conditions
- Type 2 Diabetes
- First Posted Date
- 2024-11-25
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Nimble Science Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT06704022
- Locations
- 🇨🇦
Nimble Science, Calgary, Alberta, Canada
Assessing the Safety of an IGY Supplement on the Gut Microbiome
Phase 1
Not yet recruiting
- Conditions
- HealthyMicrobiome
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Nimble Science Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT06702280
- Locations
- 🇨🇦
Nimble Science, Calgary, Alberta, Canada
The Digestion of Protein Powders in Healthy Participants Using SIMBA and LIMBA Capsule
Not Applicable
Recruiting
- Conditions
- Amino Acid ChangeMicrotiaFood ScienceNutritionDigestion Rate
- Interventions
- Dietary Supplement: Milk Protein ConcentrateDietary Supplement: Micellar Casein Isolate
- First Posted Date
- 2024-05-01
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Nimble Science Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT06394687
- Locations
- 🇨🇦
Cumming School of Medicine, Calgary, Alberta, Canada
The Safety And Efficacy Of A Probiotic Intervention On Lactulose Hydrogen Breath Test-Positive Patients And Related Gastrointestinal Symptoms
Not Applicable
Recruiting
- Conditions
- SIBOSmall Intestinal Bacterial Overgrowth
- Interventions
- Dietary Supplement: Probiotic
- First Posted Date
- 2024-03-19
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Nimble Science Ltd.
- Target Recruit Count
- 105
- Registration Number
- NCT06317441
- Locations
- 🇨🇦
Nimble Science, Calgary, Alberta, Canada
Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease
Active, not recruiting
- Conditions
- Parkinson Disease
- Interventions
- Device: Fluid biopsy capsuleDrug: Levodopa-Carbidopa Immediate Release
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- Nimble Science Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT06003608
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
Evaluation of the Microbiome in Multiple Sclerosis
Not Applicable
Terminated
- Conditions
- Multiple Sclerosis
- Interventions
- Device: SIMBA Capsule
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Nimble Science Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT05844826
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis
Recruiting
- Conditions
- Irritable Bowel SyndromeFunctional DyspepsiaType 2 DiabetesCrohn DiseaseCeliac DiseaseUlcerative ColitisHealthy
- Interventions
- Device: fluid biopsy capsule
- First Posted Date
- 2022-12-01
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Nimble Science Ltd.
- Target Recruit Count
- 300
- Registration Number
- NCT05633706
- Locations
- 🇨🇦
Nimble Science, Calgary, Alberta, Canada
Dietary Intervention Detection in the Small Intestine
Not Applicable
Completed
- Conditions
- Proof of Concept
- Interventions
- Device: Ingestible CapsuleDietary Supplement: Probiotic
- First Posted Date
- 2020-07-28
- Last Posted Date
- 2021-09-08
- Lead Sponsor
- Nimble Science Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT04489329
- Locations
- 🇨🇦
Cumming School of Medicine, Calgary, Alberta, Canada
© Copyright 2025. All Rights Reserved by MedPath